These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8758998)

  • 1. High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site.
    Ramesh N; Kim ST; Wei MQ; Khalighi M; Osborne WR
    Nucleic Acids Res; 1996 Jul; 24(14):2697-700. PubMed ID: 8758998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
    Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
    Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
    Harries M; Phillipps N; Anderson R; Prentice G; Collins M
    J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
    Furler S; Paterna JC; Weibel M; Büeler H
    Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q vectors, bicistronic retroviral vectors for gene transfer.
    Julius MA; Yan Q; Zheng Z; Kitajewski J
    Biotechniques; 2000 Apr; 28(4):702-8. PubMed ID: 10769748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricistronic and tetracistronic retroviral vectors for gene transfer.
    De Felipe P; Izquierdo M
    Hum Gene Ther; 2000 Sep; 11(13):1921-31. PubMed ID: 10986564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
    Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
    Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Sadelain M; Lucheroni F; Mannoni P; Stella CC; Martelli MF; Tabilio A
    Leuk Res; 1997 Oct; 21(10):951-9. PubMed ID: 9403006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease.
    Sugimoto Y; Aksentijevich I; Murray GJ; Brady RO; Pastan I; Gottesman MM
    Hum Gene Ther; 1995 Jul; 6(7):905-15. PubMed ID: 7578409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression.
    Royer Y; Menu C; Liu X; Constantinescu SN
    DNA Cell Biol; 2004 Jun; 23(6):355-65. PubMed ID: 15231069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
    Sokolic RA; Sekhsaria S; Sugimoto Y; Whiting-Theobald N; Linton GF; Li F; Gottesman MM; Malech HL
    Blood; 1996 Jan; 87(1):42-50. PubMed ID: 8547675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of improved adenosine deaminase retroviral vectors.
    Onodera M; Nelson DM; Yachie A; Jagadeesh GJ; Bunnell BA; Morgan RA; Blaese RM
    J Virol; 1998 Mar; 72(3):1769-74. PubMed ID: 9499026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.
    Stockschläder MA; Schuening FG; Graham TC; Storb R
    Gene Ther; 1994 Sep; 1(5):317-22. PubMed ID: 7584097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor expression from transduced vascular smooth muscle cells provides sustained neutrophil increases in rats.
    Lejnieks DV; Han SW; Ramesh N; Lau S; Osborne WR
    Hum Gene Ther; 1996 Aug; 7(12):1431-6. PubMed ID: 8844202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector.
    Zhou Y; Aran J; Gottesman MM; Pastan I
    Hum Gene Ther; 1998 Feb; 9(3):287-93. PubMed ID: 9508046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
    Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
    BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new bicistronic retroviral vector with strong IRES activity.
    Martin P; Albagli O; Poggi MC; Boulukos KE; Pognonec P
    BMC Biotechnol; 2006 Jan; 6():4. PubMed ID: 16409632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene.
    Metz MZ; Matsumoto L; Winters KA; Doroshow JH; Kane SE
    Virology; 1996 Mar; 217(1):230-41. PubMed ID: 8599208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.